SBC Valuation

SBC Medical Group Holdings Inc

Add to Watchlist

Advanced Chart

4.080

0(0.000%)1D

Overview
Forecast
Valuation
Earnings

SBC Relative Valuation

SBC's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, SBC is overvalued; if below, it's undervalued.

Historical Valuation

SBC Medical Group Holdings Inc (SBC) is now in the Fair zone, suggesting that its current forward PS ratio of 2.29 is considered Fairly compared with the five-year average of 3.11. The fair price of SBC Medical Group Holdings Inc (SBC) is between 2.38 to 4.82 according to relative valuation methord.

Relative Value

Fair Zone

2.38-4.82

Current Price：4.08

Fair

8.24

Trailing

Forward

0.00

EV/EBITDA

SBC Medical Group Holdings Inc. (SBC) has a current EV/EBITDA of 0.00. The 5-year average EV/EBITDA is 0.00. The thresholds are as follows: Strongly Undervalued below 0.00, Undervalued between 0.00 and 0.00, Fairly Valued between 0.00 and 0.00, Overvalued between 0.00 and 0.00, and Strongly Overvalued above 0.00. The current Forward EV/EBITDA of 0.00 falls within the Strongly Undervalued range.

3.28

EV/EBIT

SBC Medical Group Holdings Inc. (SBC) has a current EV/EBIT of 3.28. The 5-year average EV/EBIT is 0.94. The thresholds are as follows: Strongly Undervalued below -2.38, Undervalued between -2.38 and -0.72, Fairly Valued between 2.60 and -0.72, Overvalued between 2.60 and 4.26, and Strongly Overvalued above 4.26. The current Forward EV/EBIT of 3.28 falls within the Overvalued range.

2.23

SBC Medical Group Holdings Inc. (SBC) has a current PS of 2.23. The 5-year average PS is 0.99. The thresholds are as follows: Strongly Undervalued below -1.45, Undervalued between -1.45 and -0.23, Fairly Valued between 2.22 and -0.23, Overvalued between 2.22 and 3.44, and Strongly Overvalued above 3.44. The current Forward PS of 2.23 falls within the Overvalued range.

6.23

P/OCF

SBC Medical Group Holdings Inc. (SBC) has a current P/OCF of 6.23. The 5-year average P/OCF is 1.22. The thresholds are as follows: Strongly Undervalued below -3.52, Undervalued between -3.52 and -1.15, Fairly Valued between 3.59 and -1.15, Overvalued between 3.59 and 5.96, and Strongly Overvalued above 5.96. The current Forward P/OCF of 6.23 falls within the Strongly Overvalued range.

5.99

P/FCF

SBC Medical Group Holdings Inc. (SBC) has a current P/FCF of 5.99. The 5-year average P/FCF is 1.19. The thresholds are as follows: Strongly Undervalued below -3.42, Undervalued between -3.42 and -1.12, Fairly Valued between 3.49 and -1.12, Overvalued between 3.49 and 5.79, and Strongly Overvalued above 5.79. The current Forward P/FCF of 5.99 falls within the Strongly Overvalued range.

SBC Medical Group Holdings Inc (SBC) has a current Price-to-Book (P/B) ratio of 1.72. Compared to its 3-year average P/B ratio of 1.06 , the current P/B ratio is approximately 61.70% higher. Relative to its 5-year average P/B ratio of 1.06, the current P/B ratio is about 61.70% higher. SBC Medical Group Holdings Inc (SBC) has a Forward Free Cash Flow (FCF) yield of approximately -2.74%. Compared to its 3-year average FCF yield of 12.98%, the current FCF yield is approximately -121.11% lower. Relative to its 5-year average FCF yield of 12.98% , the current FCF yield is about -121.11% lower.

1.72

P/B

Median3y

1.06

Median5y

1.06

-2.81

FCF Yield

Median3y

12.98

Median5y

12.98

Competitors Valuation Multiple

The average P/S ratio for SBC's competitors is 1.28, providing a benchmark for relative valuation. SBC Medical Group Holdings Inc Corp (SBC) exhibits a P/S ratio of 2.23, which is 74.74% above the industry average. Given its robust revenue growth of -18.35%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap

SBC.O

SBC Medical Group Holdings Inc

International Money Express Inc

Tectonic Therapeutic Inc

Performance Decomposition

Market capitalization of SBC decreased by 60.47% over the past 1 year. The primary factor behind the change was an increase in P/E Change from 8.73 to 12.38.

The secondary factor is the Revenue Growth, contributed -18.35%to the performance.

Overall, the performance of SBC in the past 1 year is driven by P/E Change. Which is more unsustainable.

-18.35%

53.10M → 43.36M

Revenue Growth

-83.89%

34.95 → 5.63

Margin Expansion

41.77%

8.73 → 12.38

P/E Change

-60.47%